Who are Iambic Therapeutics's decision-makers?
Iambic Therapeutics is led by Tom Miller, Co-founder and CEO, with a leadership bench spanning product, science, operations, and commercialization.
- CEO
- Tom Miller
- Key exec
- Fred Manby
- Founded
- 2019
- Employees
- Private; biotech R&D organization
- HQ
- San Diego, California
- Notable
- Former professor and computational chemistry researcher.
- Tom MillerCo-founder and CEOCo-founder · since 2019Former professor and computational chemistry researcher.
- Fred ManbyCo-founder and CTOCo-founderComputational chemistry scientist.
- Michael BrownChief Scientific OfficerExecutiveDrug-discovery executive guiding pipeline science.
Who leads Iambic Therapeutics?
Tom Miller serves as Co-founder and CEO; Fred Manby serves as Co-founder and CTO; Michael Brown serves as Chief Scientific Officer. The leadership pattern reflects the company's focus on ai drug discovery.
For outreach, leadership background matters because it shows whether decisions are likely to be product-led, science-led, clinical, industrial, or government-procurement heavy.
Who actually makes buying decisions at Iambic Therapeutics?
Likely buying committees include the executive owner of OrbNet, security and compliance leaders, finance/procurement, and the technical leaders responsible for integration.
A seller should avoid starting with a generic CEO pitch unless the offer is strategic. Most practical deals will need a functional champion who owns deployment pain and a finance or operations approver.
How is Iambic Therapeutics organized as it scales?
Iambic Therapeutics's public footprint suggests a scaling private company with cross-functional teams around product, engineering, customer deployment, and go-to-market or R&D. Exact reporting lines are not public.
The safest assumption is a matrixed buying process: technical validation first, operational proof second, and executive approval for larger commitments.
As of June 2026.Sources:Iambic Therapeutics websiteIambic Series B announcement
Iambic Therapeutics — frequently asked questions
